DD282393A5 - Mycoplasma impfstoff - Google Patents

Mycoplasma impfstoff Download PDF

Info

Publication number: DD282393A5
Authority: DD; German Democratic Republic
Prior art keywords: strain; vaccine; intervet; infection; mycoplasma
Prior art date: 1987-09-18

Application number

DD88319874A

Other languages

German (de)

English (en)

Inventor

Paul K Storm

Original Assignee

��@�K@�Kk��

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-09-18

Filing date

1988-09-16

Publication date

1990-09-12

1988-09-16 Application filed by ��@�K@�Kk�� filed Critical ��@�K@�Kk��

1990-09-12 Publication of DD282393A5 publication Critical patent/DD282393A5/de

Links

229960005486 vaccine Drugs 0.000 title claims abstract description 38
241000204031 Mycoplasma Species 0.000 title abstract description 7
244000144977 poultry Species 0.000 claims abstract description 9
206010028470 Mycoplasma infections Diseases 0.000 claims abstract description 7
238000000034 method Methods 0.000 claims abstract description 5
238000002360 preparation method Methods 0.000 claims abstract description 3
241000204022 Mycoplasma gallisepticum Species 0.000 claims description 21
241000894006 Bacteria Species 0.000 claims description 6
230000001900 immune effect Effects 0.000 claims description 5
239000002671 adjuvant Substances 0.000 claims description 2
239000003381 stabilizer Substances 0.000 claims description 2
230000003115 biocidal effect Effects 0.000 claims 1
230000003053 immunization Effects 0.000 claims 1
230000002779 inactivation Effects 0.000 claims 1
239000000825 pharmaceutical preparation Substances 0.000 claims 1
241000287828 Gallus gallus Species 0.000 abstract description 27
235000013330 chicken meat Nutrition 0.000 abstract description 27
241000286209 Phasianidae Species 0.000 abstract description 8
235000013594 poultry meat Nutrition 0.000 abstract description 8
241000204003 Mycoplasmatales Species 0.000 abstract description 6
230000001717 pathogenic effect Effects 0.000 abstract description 2
LWGJTAZLEJHCPA-UHFFFAOYSA-N n-(2-chloroethyl)-n-nitrosomorpholine-4-carboxamide Chemical compound ClCCN(N=O)C(=O)N1CCOCC1 LWGJTAZLEJHCPA-UHFFFAOYSA-N 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 description 29
238000002255 vaccination Methods 0.000 description 17
241001465754 Metazoa Species 0.000 description 9
230000007850 degeneration Effects 0.000 description 8
230000002611 ovarian Effects 0.000 description 8
210000004712 air sac Anatomy 0.000 description 7
238000002474 experimental method Methods 0.000 description 6
210000001672 ovary Anatomy 0.000 description 6
239000000725 suspension Substances 0.000 description 5
235000013601 eggs Nutrition 0.000 description 4
238000004519 manufacturing process Methods 0.000 description 4
239000000443 aerosol Substances 0.000 description 3
238000002955 isolation Methods 0.000 description 3
230000001018 virulence Effects 0.000 description 3
ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
206010061218 Inflammation Diseases 0.000 description 2
238000001856 aerosol method Methods 0.000 description 2
229960000723 ampicillin Drugs 0.000 description 2
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
239000003242 anti bacterial agent Substances 0.000 description 2
229940088710 antibiotic agent Drugs 0.000 description 2
230000000740 bleeding effect Effects 0.000 description 2
239000000969 carrier Substances 0.000 description 2
230000007423 decrease Effects 0.000 description 2
229940031551 inactivated vaccine Drugs 0.000 description 2
230000004054 inflammatory process Effects 0.000 description 2
238000011081 inoculation Methods 0.000 description 2
239000002054 inoculum Substances 0.000 description 2
230000000384 rearing effect Effects 0.000 description 2
230000028327 secretion Effects 0.000 description 2
235000020183 skimmed milk Nutrition 0.000 description 2
UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
208000024891 symptom Diseases 0.000 description 2
241000271566 Aves Species 0.000 description 1
241000282421 Canidae Species 0.000 description 1
208000014085 Chronic respiratory disease Diseases 0.000 description 1
102100031780 Endonuclease Human genes 0.000 description 1
108010042407 Endonucleases Proteins 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
241000202942 Mycoplasma synoviae Species 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
239000001888 Peptone Substances 0.000 description 1
108010080698 Peptones Proteins 0.000 description 1
BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
239000004365 Protease Substances 0.000 description 1
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
241000282898 Sus scrofa Species 0.000 description 1
229930194936 Tylosin Natural products 0.000 description 1
239000004182 Tylosin Substances 0.000 description 1
241000700605 Viruses Species 0.000 description 1
FQVHOULQCKDUCY-OGHXVOSASA-N [(2s,3s,4r,6s)-6-[(2r,3s,4r,5r,6s)-6-[[(1s,3r,7r,8s,9s,10r,12r,14e,16s)-7-acetyloxy-8-methoxy-3,12-dimethyl-5,13-dioxo-10-(2-oxoethyl)-4,17-dioxabicyclo[14.1.0]heptadec-14-en-9-yl]oxy]-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2,4-dimeth Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@H]1[C@@H](CC=O)C[C@@H](C)C(=O)/C=C/[C@@H]2O[C@H]2C[C@@H](C)OC(=O)C[C@H]([C@@H]1OC)OC(C)=O)[C@H]1C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O1 FQVHOULQCKDUCY-OGHXVOSASA-N 0.000 description 1
238000005273 aeration Methods 0.000 description 1
229960001212 bacterial vaccine Drugs 0.000 description 1
238000009395 breeding Methods 0.000 description 1
230000001488 breeding effect Effects 0.000 description 1
244000144987 brood Species 0.000 description 1
239000005018 casein Substances 0.000 description 1
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
235000021240 caseins Nutrition 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 description 1
CYDMQBQPVICBEU-XRNKAMNCSA-N chlortetracycline Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-XRNKAMNCSA-N 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
230000001584 effect on egg Effects 0.000 description 1
230000000694 effects Effects 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
229960003276 erythromycin Drugs 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
230000002458 infectious effect Effects 0.000 description 1
239000007788 liquid Substances 0.000 description 1
244000144972 livestock Species 0.000 description 1
238000011068 loading method Methods 0.000 description 1
239000000463 material Substances 0.000 description 1
244000005700 microbiome Species 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
235000019319 peptone Nutrition 0.000 description 1
229960003531 phenolsulfonphthalein Drugs 0.000 description 1
230000010076 replication Effects 0.000 description 1
210000002345 respiratory system Anatomy 0.000 description 1
230000000405 serological effect Effects 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
239000007921 spray Substances 0.000 description 1
238000003756 stirring Methods 0.000 description 1
229960005322 streptomycin Drugs 0.000 description 1
239000000126 substance Substances 0.000 description 1
208000011580 syndromic disease Diseases 0.000 description 1
239000008399 tap water Substances 0.000 description 1
235000020679 tap water Nutrition 0.000 description 1
WBPYTXDJUQJLPQ-VMXQISHHSA-N tylosin Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CC=O)CO[C@H]1[C@@H]([C@H](OC)[C@H](O)[C@@H](C)O1)OC)CC)[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1 WBPYTXDJUQJLPQ-VMXQISHHSA-N 0.000 description 1
229960004059 tylosin Drugs 0.000 description 1
235000019375 tylosin Nutrition 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/544—Mucosal route to the airways
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/826—Bacterial vaccine for avian species, e.g. poultry or other birds

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Immunology (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

DD88319874A 1987-09-18 1988-09-16 Mycoplasma impfstoff DD282393A5 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
NL8702232		1987-09-18

Publications (1)

Publication Number	Publication Date
DD282393A5 true DD282393A5 (de)	1990-09-12

Family

ID=19850632

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DD88319874A DD282393A5 (de)	1987-09-18	1988-09-16	Mycoplasma impfstoff

Country Status (18)

Country	Link
US (1)	US5064647A (sh)
EP (1)	EP0307976B1 (sh)
JP (1)	JP2718518B2 (sh)
KR (1)	KR970003054B1 (sh)
AR (1)	AR242339A1 (sh)
AU (1)	AU608058B2 (sh)
CA (1)	CA1336262C (sh)
DD (1)	DD282393A5 (sh)
DE (1)	DE3881993T2 (sh)
DK (1)	DK175065B1 (sh)
ES (1)	ES2058237T3 (sh)
HU (1)	HU203841B (sh)
IE (1)	IE61398B1 (sh)
IL (1)	IL87359A (sh)
NZ (1)	NZ226208A (sh)
PT (1)	PT88524B (sh)
YU (1)	YU46552B (sh)
ZA (1)	ZA885707B (sh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5215914A (en) *	1986-06-18	1993-06-01	American Registry Of Pathology	Adherent and invasive mycoplasma
DE68914883T2 (de) *	1988-06-02	1994-08-18	Nippon Zeon Co	Geflügel-Mycoplasma-Antigene und das Gen enthaltende rekombinante Vektoren sowie Diagnostika und Vakzine, die diese verwenden.
USRE39494E1 (en) *	1992-02-27	2007-02-27	Intervet Inc.	Inactivated mycoplasma hyopneumoniae and uses therefor
US5338543A (en) *	1992-02-27	1994-08-16	Ambico, Inc.	Thimerosal inactivated mycoplasma hyopneumoniae vaccine
ZA9710606B (en) *	1996-12-05	1998-06-12	Akzo Nobel Nv	Non-virulent Mycoplasma synoviae vaccine thereof.
EP0846468B1 (en) *	1996-12-05	2004-06-09	Akzo Nobel N.V.	Non-virulent mycoplasma synoviae and vaccine thereof
US20070003508A1 (en)	2005-07-01	2007-01-04	Wooley Richard E	Methods and compositions for promoting wound healing
US20040151765A1 (en) *	2001-09-18	2004-08-05	Ritchie Branson W.	Methods and compositions for wound management
US20040208842A1 (en) *	2001-09-18	2004-10-21	Ritchie Branson W.	Antimicrobial cleansing compositions and methods of use
PT1474067E (pt)	2001-07-02	2008-11-14	Pfizer Prod Inc	Vacinação numa dose com mycoplasma hyopneumoniae
US7217420B2 (en) *	2002-07-13	2007-05-15	The University Of Georgia Research Foundation, Inc.	Mycoplasma gallisepticum formulation
US20070185202A1 (en) *	2004-03-03	2007-08-09	University Of Georgia Research Foundation, Inc.	Methods and compositions for ophthalmic treatment of fungal and bacterial infections
US20090068231A1 (en) *	2007-09-11	2009-03-12	Wyeth	Live attenuated mycoplasma strains
TW200918666A (en) *	2007-09-11	2009-05-01	Wyeth Corp	Attenuated mycoplasma gallisepticum strains
JP2025510684A (ja) *	2022-04-06	2025-04-15	ユニバーシティオブジョージアリサーチファンデーション，インコーポレーテッド	マイコプラズマ・ガリセプティカム生ワクチン

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3534136A (en) *	1969-09-19	1970-10-13	Research Corp	M.g. inoculum for poultry
JPS5540568B2 (sh) *	1972-10-05	1980-10-18
JPS52134019A (en) *	1976-04-28	1977-11-09	Biseibutsu Kagaku Kenkiyuushiy	Micoplasma galicepticum infection vaccine

1988
- 1988-07-28 DE DE88201623T patent/DE3881993T2/de not_active Expired - Lifetime
- 1988-07-28 ES ES88201623T patent/ES2058237T3/es not_active Expired - Lifetime
- 1988-07-28 EP EP88201623A patent/EP0307976B1/en not_active Expired - Lifetime
- 1988-08-02 IE IE236188A patent/IE61398B1/en not_active IP Right Cessation
- 1988-08-03 ZA ZA885707A patent/ZA885707B/xx unknown
- 1988-08-05 IL IL87359A patent/IL87359A/xx not_active IP Right Cessation
- 1988-08-12 US US07/231,913 patent/US5064647A/en not_active Expired - Lifetime
- 1988-09-14 YU YU173588A patent/YU46552B/sh unknown
- 1988-09-15 AR AR88311952A patent/AR242339A1/es active
- 1988-09-16 CA CA000577610A patent/CA1336262C/en not_active Expired - Lifetime
- 1988-09-16 PT PT88524A patent/PT88524B/pt not_active IP Right Cessation
- 1988-09-16 JP JP63232157A patent/JP2718518B2/ja not_active Expired - Lifetime
- 1988-09-16 DD DD88319874A patent/DD282393A5/de unknown
- 1988-09-16 DK DK198805200A patent/DK175065B1/da active
- 1988-09-16 KR KR1019880012000A patent/KR970003054B1/ko not_active Expired - Lifetime
- 1988-09-16 HU HU884883A patent/HU203841B/hu unknown
- 1988-09-16 NZ NZ226208A patent/NZ226208A/xx unknown
- 1988-09-16 AU AU22334/88A patent/AU608058B2/en not_active Expired

Also Published As

Publication number	Publication date
JPH01131123A (ja)	1989-05-24
AU608058B2 (en)	1991-03-21
KR890004726A (ko)	1989-05-09
EP0307976A1 (en)	1989-03-22
IL87359A (en)	1992-11-15
EP0307976B1 (en)	1993-06-23
IE882361L (en)	1989-03-18
YU46552B (sh)	1993-11-16
HUT47866A (en)	1989-04-28
US5064647A (en)	1991-11-12
DK175065B1 (da)	2004-05-17
PT88524A (pt)	1988-10-01
ZA885707B (en)	1989-04-26
IE61398B1 (en)	1994-11-02
NZ226208A (en)	1991-02-26
PT88524B (pt)	1992-11-30
ES2058237T3 (es)	1994-11-01
AU2233488A (en)	1989-03-23
AR242339A1 (es)	1993-03-31
DE3881993T2 (de)	1993-09-30
IL87359A0 (en)	1989-01-31
HU203841B (en)	1991-10-28
YU173588A (en)	1990-02-28
JP2718518B2 (ja)	1998-02-25
CA1336262C (en)	1995-07-11
DK520088A (da)	1989-03-19
KR970003054B1 (ko)	1997-03-14
DE3881993D1 (en)	1993-07-29
DK520088D0 (da)	1988-09-16

Legal Events

Date	Code	Title	Description
2004-04-28	IF04	In force in the year 2004	Expiry date: 20080917

Publication	Publication Date	Title
DE69637251T2 (de)	2008-06-12	Kultivierung von Lawsonia intracellularis, Impfstoffe gegen Lawsonia intracellularis und diagnostische Mittel
DE69632235T2 (de)	2004-08-26	Newcastle-Krankheitsvirus-Kombinationsimpfstoff
DE69925371T2 (de)	2006-01-19	Impfstoff für geflügel
DE60012042T2 (de)	2005-07-07	Entepneumovirus und entsprechendes impfstoff
DE3881993T2 (de)	1993-09-30	Mycoplasma-Impfstoff.
DE2348897C3 (de)	1980-02-14	In die Atmungswege verabreichbarer Impfstoff zur Immunisierung von Tieren gegen Mycoplasmose der Atmungsorgane
DE69426051T2 (de)	2001-05-10	Impfstoff für Geflügel
DE2836507C2 (sh)	1990-03-15
DE60011560T2 (de)	2005-08-18	Salmonella Impfstoff, der keinen Antikörper gegen Flagellin oder gegen Flagella induziert
DE2708668A1 (de)	1977-09-08	Nd-impfstoff und verfahren zu seiner herstellung
DE2817891A1 (de)	1978-11-09	Nd-impfstoff und verfahren zu seiner herstellung
DE69216732T2 (de)	1997-06-12	Impfstoff gegen den Geflügelanämieerreger
DD232822A5 (de)	1986-02-12	Verfahren zur herstellung eines viruspraeparates gegen die mareksche gefluegelkrankheit
DE69306934T2 (de)	1997-05-28	Geflügelkrankheit verursachende neue bakterie und daraus stammender impfstoff
DE69729425T2 (de)	2005-06-09	Nicht-virulentes Mycoplasma synoviae und Impfstoffe desselben
DE69615772T2 (de)	2002-08-01	Milder Newcastle-Krankheitsimpfstoff
DE69328341T2 (de)	2000-12-14	Impfstoff gegen infektiöse Bursal-Krankheit
DE69103130T2 (de)	1994-12-01	Zellfreies Marekskrankheitvirus-Vakzin.
EP0642796B1 (de)	2001-12-05	Salmonella-Lebendimpfstoff
DE69615656T2 (de)	2002-08-01	Aviären infektiösen anämie mastgeflügel impfstoff
DE2058645C2 (de)	1982-02-11	Verfahren zur Herstellung eines stark abgeschwächten Newcastle-Disease-Virus-Lebendimpfstoffs
DE3878982T2 (de)	1993-07-22	Abgeschwaechtes virus und impfstoffe davon zur verwendung gegen infektionen bei gefluegel, verursacht durch truthahn-rhinotracheitis-virus.
EP0013449A1 (en)	1980-07-23	Vaccine against diseases caused by reo viruses, combined vaccine with Newcastle disease virus, process for preparing them and reo virus strain used for their preparation
US4515777A (en)	1985-05-07	Vaccines
DE3136430C2 (sh)	1989-06-08